These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 8565298)

  • 21. Detection of antibodies to p24 and gp41 epitopes of HIV by ELISA using the recombinant core protein (p24) and envelope synthetic protein (gp41).
    Filice G; Soldini L; Orsolini P; Razzini E; Chiapparoli L; Gulminetti R; Cattaneo E; Achilli G
    Microbiologica; 1991 Jan; 14(1):1-7. PubMed ID: 1906127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of serum antigen and antibody concentration with clinical features in HIV infection.
    Ellaurie M; Rubinstein A
    Arch Dis Child; 1991 Feb; 66(2):200-3. PubMed ID: 1705767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1.
    Binley JM; Klasse PJ; Cao Y; Jones I; Markowitz M; Ho DD; Moore JP
    J Virol; 1997 Apr; 71(4):2799-809. PubMed ID: 9060635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The absence of loss of antibodies of high affinity to human immunodeficiency virus (HIV) is associated with disease progression in HIV-1-infected patients.
    Chargelegue D; Stanley CM; O'Toole CM; Colvin BT; Steward MW
    J Infect Dis; 1995 Sep; 172(3):897-8. PubMed ID: 7658093
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-HIV-1 antibody avidity is correlated with clinical status in infected children.
    Sciascia C; Palomba E; Gay V; Tovo PA
    Pediatr AIDS HIV Infect; 1996 Feb; 7(1):14-9. PubMed ID: 11361468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of antibodies to the core protein P17, a serological marker during HIV-1 infection.
    Mehta SU; Rupprecht KR; Hunt JC; Kramer DE; McRae BJ; Allen RG; Dawson GJ; Devare SG
    AIDS Res Hum Retroviruses; 1990 Apr; 6(4):443-54. PubMed ID: 1692727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection.
    Cheingsong-Popov R; Panagiotidi C; Bowcock S; Aronstam A; Wadsworth J; Weber J
    BMJ; 1991 Jan; 302(6767):23-6. PubMed ID: 1899349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of HIV-1 infection by detection of antibody IgG to HIV-1 in urine with ultrasensitive enzyme immunoassay (immune complex transfer enzyme immunoassay) using recombinant proteins as antigens.
    Hashida S; Hashinaka K; Saitoh A; Takamizawa A; Shinagawa H; Oka S; Shimada K; Hirota K; Kohno T; Ishikawa S
    J Clin Lab Anal; 1994; 8(4):237-46. PubMed ID: 7523637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strongly enhanced sensitivity of a direct anti-HIV-1/-2 assay in seroconversion by incorporation of HIV p24 ag detection: a new generation vironostika HIV Uni-Form II.
    van Binsbergen J; Keur W; Siebelink A; van de Graaf M; Jacobs A; de Rijk D; Nijholt L; Toonen J; Gürtler LG
    J Virol Methods; 1998 Dec; 76(1-2):59-71. PubMed ID: 9923740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shortening of the window period in diagnosis of HIV-1 infection by simultaneous detection of p24 antigen and antibody IgG to p17 and reverse transcriptase in serum with ultrasensitive enzyme immunoassay.
    Hashida S; Hashinaka K; Nishikata I; Oka S; Shimada K; Saito A; Takamizawa A; Shinagawa H; Ishikawa E
    J Virol Methods; 1996 Oct; 62(1):43-53. PubMed ID: 8910647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities.
    Koup RA; Pikora CA; Luzuriaga K; Brettler DB; Day ES; Mazzara GP; Sullivan JL
    J Exp Med; 1991 Dec; 174(6):1593-600. PubMed ID: 1744586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative analysis of human immunodeficiency virus type 1 antibody reactivity by western immunoblots: evaluation of relative antibody levels in seropositive individuals and mothers.
    Geffin RB; Lai SH; Hutto C; Scott GB; Scott WA; Master M; Parks WP
    J Infect Dis; 1992 Jan; 165(1):111-8. PubMed ID: 1727880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune complex transfer enzyme immunoassay for antibody IgM to HIV-1 p17 antigen.
    Hashida S; Ishikawa S; Nishikata I; Hashinaka K; Oka S; Ishikawa E
    J Clin Lab Anal; 1998; 12(6):329-36. PubMed ID: 9850183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maternal humoral factors associated with perinatal human immunodeficiency virus type-1 transmission in a cohort from Kigali, Rwanda, 1988-1994.
    Tranchat C; Van de Perre P; Simonon-Sorel A; Karita E; Benchaïb M; Lepage P; Desgranges C; Boyer V; Trépo C
    J Infect; 1999 Nov; 39(3):213-20. PubMed ID: 10714798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Earlier diagnosis of HIV-1 infection by simultaneous detection of p24 antigen and antibody IgGs to p17 and reverse transcriptase in serum with enzyme immunoassay.
    Hashida S; Hashinaka K; Nishikata I; Saito A; Takamizawa A; Shinagawa H; Ishikawa E
    J Clin Lab Anal; 1996; 10(4):213-9. PubMed ID: 8811465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression.
    Zwart G; van der Hoek L; Valk M; Cornelissen MT; Baan E; Dekker J; Koot M; Kuiken CL; Goudsmit J
    Virology; 1994 Jun; 201(2):285-93. PubMed ID: 7514319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yeast-expressed p55 precursor core protein of human immunodeficiency virus type 1 does not elicit protective immunity in chimpanzees.
    Emini EA; Schleif WA; Quintero JC; Conard PG; Eichberg JW; Vlasuk GP; Lehman ED; Polokoff MA; Schaeffer TF; Schultz LD
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1247-50. PubMed ID: 2127681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a flow cytometric model for monitoring HIV antigen expression in vitro.
    Heynen CA; Holzer TJ
    J Immunol Methods; 1992 Jul; 152(1):25-33. PubMed ID: 1640108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Titer of anti-P24 and anti-GP41 antibodies as a diagnostic parameter in patients with asymptomatic and symptomatic HIV infections].
    Radkowski M; Laskus T; Babiuch L; Slusarczyk J
    Pol Arch Med Wewn; 1991 Dec; 86(6):355-9. PubMed ID: 1819786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.